The pros and cons of HCQ dosing guidelines to limit potential eye toxicity were explored at this year’s ACR/ARHP Annual Meeting.
Reducing or eliminating these foods may help control gout and minimize frequency of attacks.
Findings from the first study to incorporate a meta-analysis on TNFi dose adjustment in an axSpA population.
Recent studies identify a counterintuitive risk factor, as well as 2 predictors of accelerated knee osteoarthritis.
Seropositivity was strongly associated with ILD risk in this large prospective cohort study.
What’s new in Sjögren syndrome: (1) clinical clues herald progression to a life-threatening variant and (2) a common therapy exacerbates comorbidities.
British researchers quantified the burden of continuing weight gain on the risk of PsA.
Recent studies explore the vascular underpinnings of neuropsychiatric damage as well as the risk of resistant hypertension in patients with SLE.
Be alert for the development of uveitis in older patients with gout, especially those who have multiple comorbidities.
Five questions to test your knowledge of the prevalence, risk, and classification of RA.